Results 131 to 140 of about 6,922 (185)

Shengjiang San suppresses C5a/C5aR1-mediated neutrophil activation and NET formation to alleviate acute lung injury. [PDF]

open access: yesFront Pharmacol
Zhang D   +12 more
europepmc   +1 more source

The C5a-C5aR1 axis facilitates blood-brain barrier disruption induced by EV-A71 infection through neutrophil activation. [PDF]

open access: yesPLoS Pathog
Zhu P   +15 more
europepmc   +1 more source

Effects of overexpression of PAD4 enzyme in mouse synovium

open access: yes, 2005
Zendman, AJW   +8 more
openaire   +1 more source

PAD4 Takes Charge During Neutrophil Activation: Impact of PAD4 Mediated NET Formation on Immune-Mediated Disease

open access: yesJournal of Thrombosis and Haemostasis, 2021
Peptidyl arginine deiminase 4 (PAD4) is an enzyme that converts arginine into citrulline. PAD4 is expressed in neutrophils that, when activated, can drive the formation of neutrophil extracellular traps (NETs). Uncontrolled activation of PAD4 and subsequent citrullination of proteins is increasingly recognized as a driver of (auto)immune diseases ...
Chris P M Reutelingsperger   +2 more
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Autoantibodies to PAD4 and BRAF in rheumatoid arthritis

Autoimmunity Reviews, 2012
Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes cartilage and bone destruction. The mechanisms leading to RA are unknown. There is currently no reliable cure for RA. Early treatment can reduce inflammation, joint damage and bone destruction. Thus, early diagnosis of RA is critical.
Auger, Isabelle   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy